Abstract
Objective
Some studies have found that prostate cancer (PCa) screening provides little or no change in PCa-related mortality during the 7–10 years following diagnoses. However, most men are diagnosed with PCa at low-stage disease and die of unrelated causes during this period. Men diagnosed at stage IV are at much higher risk of dying of the disease. Therefore, stage IV rates at first diagnoses may be a surrogate marker of PCa-related mortality over a time span less than 10 years. The study objective is to examine the association between PCa screening and stage IV disease rates in new cases to explore potential benefits for PCa screening.
Materials and methods
The percent of stages I, II, III, IV and unclassified PCa diagnosed in white males in 2005 was compared to PCa screening rates on a state-by-state basis. To consider access to medical care and socioeconomic status, median family income, degree of urbanization, urologist population density and health insurance status were included in the analysis.
Results
PCa stage IV disease correlated inversely with PCa screening rates (r = –0.42, P = 0.006) where r is the correlation coefficient and P is the probability. Stage I PCa correlated with lack of health insurance (r = 0.37, P = 0.02).
Conclusions
The results of this study suggest that with PCa screening may be associated with reduced rates of stage IV disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Cancer Society (2009) Cancer facts & figures 2009. American Cancer Society, Atlanta
Andriole GL, Crawford ED, Grubb RL III et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310–1319
Schröder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized european study. N Engl J Med 360(13):1320–1328
Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review 1975–2005, Table XXIII-5, PROSTATE CANCER SURVIVAL RATES, BY RACE, DIAGNOSIS YEAR, STAGE AND AGE, National Cancer Institute
Benchmark Reports for RACE/STAGE of Prostate Cancer Diagnosed in 2005. http://www.facs.org/cancer/ncdb/publicaccess.html. Accessed 10 April 2008
Centers for Disease Control and Prevention. National Center for Health Statistics (2006) Health data for all ages. http://www.cdc.gov/nchs/health_data_for_all_ages.htm. Accessed 8 Sep 2006
US Census Bureau Data. Accessed at: http://www.census.gov/main/www/cen2000.html. [Accessed 8 September 2006]
Knox M, Clayton D, Colli J, (2009) Prostate cancer mortality projected by stage for males diagnosed with prostate cancer in 2008 in the United States. Southeastern Section Meeting AUA, Mobile, Alabama in March 2009
Wilt TJ, Shamliyan T, Taylor B et al (2008) Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148(6):435–448
Bill-Axelson A, Holmberg L, Ruutu M et al (2005) Scandinavian Prostate Cancer Screening Group study No. 4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 12(19):1977–1984
Benchmark Reports for RACE/TREATMENT of Prostate Cancer Diagnosed in 2006. http://www.facs.org/cancer/ncdb/publicaccess.html. Accessed 10 April 2008
Greenland S (2001) Ecologic vs individual-level sources of confounding in ecologic estimates of contextual health effects. Int J Epidemiol 30:1343–1350
Nelson DE, Bland S, Powell-Griner E et al (2002) State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. AMA 287:2659–2667
Volk RJ, Cass AR (2002) The accuracy of primary care patients’self reports of prostate-specific antigen testing. Am J Prev Med 22:56–58
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Colli, J.L. The effect of prostate cancer screening on stage IV disease in America. Int Urol Nephrol 43, 391–396 (2011). https://doi.org/10.1007/s11255-010-9799-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-010-9799-3